Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
about
Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?beta-Amyloid degradation and Alzheimer's diseaseA modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeAbeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzymeCerebrovascular disease in ageing and Alzheimer's diseaseβ-Amyloid: the key peptide in the pathogenesis of Alzheimer's diseaseEndothelin-converting enzymes and related metalloproteases in Alzheimer's diseaseACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's diseaseThe genetics of Alzheimer diseaseAngiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive declineAlterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Proteomic profiling of gamma-secretase substrates and mapping of substrate requirementsIdentification of beta-secretase (BACE1) substrates using quantitative proteomics.Gestational protein restriction increases angiotensin II production in rat lung.An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.The association of angiotensin-converting enzyme with biomarkers for Alzheimer's diseaseExpression of ACE and ACE2 in patients with hypertensive nephrosclerosis.ACE polymorphism and use of ACE inhibitors: effects on memory performance.ACE variants and association with brain Aβ levels in Alzheimer's diseaseUnintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's diseaseGenome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammationAssociation of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab communityAngiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink.The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesisSite-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluidThe carboxypeptidase ACE shapes the MHC class I peptide repertoireAntihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.Telmisartan Modulates Glial Activation: In Vitro and In Vivo StudiesInfluence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brainThe involvement of lipid rafts in Alzheimer's disease.Roles of Brain Angiotensin II in Cognitive Function and Dementia.Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's diseaseDisease modifying therapy for AD?Novel modulators of amyloid-beta precursor protein processing.The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's DiseaseA Low-Protein Diet Enhances Angiotensin II Production in the Lung of Pregnant Rats but not Nonpregnant Rats.
P2860
Q21202832-6E2CF975-D1F7-41E6-BB21-2F24B02E8D0EQ21284467-6371239D-3C9B-456E-AB08-286496A80E06Q24306614-1C99D53E-7389-4A45-A44E-1D60FBCBC257Q24317730-7B1DB256-E2D1-4CD5-848E-0F0A72A19BA5Q26771852-B512ABA8-3F68-406E-98D3-35A8310D204BQ26781608-3402336C-0D19-4AD4-BA55-9F5D7848C2AFQ26862901-78A5F30B-9890-458C-8318-39F5CFFF84AAQ26866225-4D3E6583-5321-460D-9AF8-DC5B8C78997CQ27026166-1BFA7CF5-AD9D-441D-BCE7-D1CD6E2A252AQ30572684-88398135-BD5B-4159-8F97-92E469977253Q30678146-C750A965-7328-444F-A707-EBA6A8BAAACAQ30833707-93951139-4E2A-4265-99DD-71021B2C5698Q31047131-DB580C82-311D-47E7-9009-53E1A64C8BA6Q33378681-ACACD08D-500E-43F4-89B6-E79D16D5A589Q33521280-951DA496-BD8D-481E-8A85-B34690531461Q33581546-6EFCCB8D-AF54-4AF5-A9F8-C301BF5F237EQ33652202-10A6C08D-5979-4AD2-88F0-B30E8D2B1721Q33821846-39C445D3-4FED-408C-8C15-AA91DCF3E4EBQ33827868-7D9D9FAB-F779-4BE2-A441-D5747E4EE305Q33848704-28F060A2-EBD2-4774-AF64-5EC089B12083Q34310258-A82C7FA2-AA31-4A30-96BD-054E8D226C96Q34350595-EF5E22C8-9680-49DC-AE00-FE033D882F1AQ34394932-D49BCE87-0ED0-4C05-B453-91833CBE2378Q34658026-9771534C-DFE5-42A8-9EAB-B94B48779479Q35023755-C3A5F56B-C927-45B3-BBCD-49924F3B5EF2Q35050809-892FA6EE-3199-4473-B353-4DDED22A0005Q35123119-405906CD-3857-4682-858B-AA4B810F01C7Q35402189-D14E4831-E803-44CE-8A1D-5A1D87BE0AA8Q35564715-F66C1436-2FE4-4A61-8EBD-A1474CE729C6Q35613025-6286F841-FCF2-4D97-9CF0-FC871F08C879Q36019970-98852BCA-B91B-44D5-82C7-F1314CDFD267Q36036376-BF1F5D94-2588-4EF4-9BB6-4D5145642845Q36323138-4831949F-EB96-491D-A298-C10D5DDE5566Q36447798-56599163-C295-46A6-B5C8-BC5069E9DCF5Q36487749-7523AA74-BE77-45C8-B658-D75830ED9EF2Q36639258-008AF019-BD4E-42BA-85F5-6124677DE12DQ36640414-D2420B35-6755-4FDE-A621-CB108A3ECE78Q36714447-6CB84453-C119-4442-855E-43E878177FBCQ36721915-3F8C2152-6BDE-48E8-B8F9-55D868523FF6Q36861080-80A9FAE9-CF15-4435-9B28-09579A6BBFE4
P2860
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@ast
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@en
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme
@nl
type
label
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@ast
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@en
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme
@nl
prefLabel
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@ast
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@en
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme
@nl
P2860
P356
P1476
Amyloid beta-protein is degrad ...... elevated by an ACE inhibitor.
@en
P2093
Dennis J Selkoe
Matthew L Hemming
P2860
P304
37644-37650
P356
10.1074/JBC.M508460200
P407
P577
2005-09-09T00:00:00Z